Glucose-incretin interaction revisited

Abstract

Pancreatic beta cell dysfunction is pivotal to the development of diabetes, and restoration of insulin action is of primary importance. Here, we present a review of the mechanism of insulin secretion by pancreatic beta cells and discuss the mutual interaction of signaling pathways in stimulus-secretion coupling to better understand the scientific basis of pharmacological treatment for insulin secretion deficiency. Glucose stimulates insulin secretion via membrane depolarization by closure of ATP-sensitive K + channels (K ATP channels) and opening of L-type voltage-dependent Ca 2+ channels. The resultant elevation of cytosolic free Ca 2+ triggers insulin exocytosis. This is termed the "K ATP-dependent pathway" and is shared by sulfonylurea, which closes KATP channels. Glucose also stimulates insulin release independent of its action on K ATP channels. This is referred to as the "K ATP-independent pathway," the molecular basis of which remains elusive. In the pancreatic beta cell, incretin hormones increase cAMP level, which enhances glucose-stimulated insulin release by protein kinase A-dependent and -independent mechanisms. Importantly, cAMP does not directly augment Ca 2+-stimulated insulin release per se. The stimulatory level of ambient glucose is an absolute requirement for incretin to enhance insulin release. Therefore, incretin/cAMP enhances K ATP-independent insulinotropic action of glucose. The robust glucoselowering effect of DPP4 inhibitor add-on in diabetic patients with sulfonylurea secondary failure is intriguing. With the clinical availability of DPP4 inhibitor and GLP-1 mimetics, the importance of the interactions between cAMP signaling and K ATP channel-independent actions of glucose is reappraised. © The Japan Endocrine Society.